NCT04994431

Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 109 (actual)
• Sponsor: University of Massachusetts, Worcester · Academic / Other
• Sex: Male
• Age: 60 Years
• Healthy volunteers: Not accepted

Summary

Post-Operative Urinary Retention (POUR) in Thoracic Surgery is a prospective interventional study aiming to test the hypothesis that the prophylactic use of tamsulosin prior to thoracic surgery in high risk patients leads to reduce the rates of POUR.

Detailed description

Post-operative urinary retention (POUR) is one of the most common post-operative complications encountered by most surgical specialties. The incidence of POUR can vary from five to 70%. Post-operative urinary retention is a prevalent complication. Patients who undergo thoracic surgery have greater urinary retention rates compared to others. Data on effective methods to reduce the risk of POUR in this high-risk group are limited. All subjects who meet inclusion and exclusion criteria will be invited to participate. There will be no randomization. All will receive tamsulosin in the pre operative period.

Conditions

• Thoracic Diseases
• Urinary Retention

Interventions

Type	Name	Description
DRUG	Tamsulosin Hydrochloride	0.4mg orally nightly for the two days immediately prior to surgery and the morning of surgery.

Timeline

• Start date: 2021-08-01
• Primary completion: 2023-10-04
• Completion: 2023-10-04
• First posted: 2021-08-06
• Last updated: 2024-11-07
• Results posted: 2024-11-07

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study